Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.12 trillion and total revenue of $111.32 billion.
Market Cap
1.12T
Revenue
111.32B
Profits
-41.65B
PE Ratio
n/a
Profit Margin
-37.42%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.90B | -2.99% | 1,288,894 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 71.04B | -2.05% | 728,002 | 14.92B |
| 3 | ARGX | argenx SE | 50.39B | -2.77% | 326,376 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.32B | -2.20% | 1,149,615 | 4.29B |
| 5 | ONC | BeOne Medicines AG | 32.60B | -3.73% | 269,789 | 5.70B |
| 6 | RVMD | Revolution Medicines, Inc. | 30.97B | -2.55% | 2,475,698 | - |
| 7 | RPRX | Royalty Pharma plc | 30.43B | -0.59% | 4,264,784 | 2.44B |
| 8 | INSM | Insmed Incorporated | 23.66B | -5.60% | 3,688,412 | 819.56M |
| 9 | BNTX | BioNTech SE | 22.65B | -2.65% | 1,169,040 | 3.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.96B | -0.71% | 7,211,623 | 13.31M |
| 11 | MRNA | Moderna, Inc. | 19.46B | -1.98% | 7,233,073 | 2.23B |
| 12 | INCY | Incyte Corporation | 19.04B | -2.38% | 1,648,990 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.20B | -1.34% | 1,362,310 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.93B | -2.06% | 471,347 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.35B | -0.99% | 1,346,290 | 4.44B |
| 16 | SMMT | Summit Therapeutics Inc. | 13.09B | -7.00% | 2,115,846 | - |
| 17 | BBIO | BridgeBio Pharma, Inc. | 12.95B | -5.07% | 2,693,408 | 579.96M |
| 18 | EXEL | Exelixis, Inc. | 12.60B | -1.90% | 2,068,925 | 2.38B |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.27B | -1.92% | 2,119,178 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.07B | -3.00% | 222,452 | 1.13B |
| 21 | AXSM | Axsome Therapeutics, Inc. | 11.72B | -1.96% | 548,340 | 708.24M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.80B | -3.79% | 1,746,815 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.01B | -2.69% | 2,076,132 | 3.24B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.57B | -5.35% | 942,842 | 5.37M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.55B | -0.85% | 343,665 | 7.46M |
| 26 | CYTK | Cytokinetics, Incorporated | 9.44B | -3.55% | 1,829,688 | 105.82M |
| 27 | KRYS | Krystal Biotech, Inc. | 9.03B | -3.16% | 316,492 | 417.30M |
| 28 | IBRX | ImmunityBio, Inc. | 8.35B | -2.21% | 11,347,554 | 140.98M |
| 29 | NUVL | Nuvalent, Inc. | 8.08B | -2.02% | 798,461 | - |
| 30 | HALO | Halozyme Therapeutics, Inc. | 7.96B | -3.02% | 2,144,681 | 1.51B |
| 31 | PCVX | Vaxcyte, Inc. | 7.56B | -2.13% | 1,294,465 | - |
| 32 | TECH | Bio-Techne Corporation | 6.78B | -3.22% | 5,229,552 | 1.21B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 6.76B | -2.71% | 468,275 | 51.48M |
| 34 | CELC | Celcuity Inc. | 6.65B | 2.20% | 1,476,422 | - |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.57B | -3.19% | 560,751 | 74.06M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 6.51B | -0.96% | 1,958,710 | - |
| 37 | MIRM | Mirum Pharmaceuticals, Inc. | 6.23B | -8.26% | 1,672,697 | 569.61M |
| 38 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.20B | -3.32% | 532,419 | 217.17M |
| 39 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.01% | 533,372 | 15.00M |
| 40 | APGE | Apogee Therapeutics, Inc. | 6.08B | -3.30% | 714,815 | - |
| 41 | CORT | Corcept Therapeutics Incorporated | 6.05B | -3.31% | 874,503 | 769.10M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.93B | -1.72% | 843,483 | 827.11M |
| 43 | SRRK | Scholar Rock Holding Corporation | 5.91B | -3.76% | 1,346,153 | - |
| 44 | CGON | CG Oncology, Inc. | 5.90B | -3.75% | 1,181,114 | 5.07M |
| 45 | BLTE | Belite Bio, Inc | 5.63B | -4.63% | 256,534 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 5.60B | -3.16% | 1,717,192 | 700.35M |
| 47 | IMVT | Immunovant, Inc. | 5.60B | -5.08% | 1,252,034 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.59B | -4.42% | 2,078,994 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 5.26B | -2.87% | 610,330 | 7.50M |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.25B | - | - | 1.11B |
| 51 | LEGN | Legend Biotech Corporation | 5.10B | -3.67% | 1,800,147 | 1.14B |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 4.71B | 0.96% | 612,266 | 1.34M |
| 53 | CRSP | CRISPR Therapeutics AG | 4.67B | -4.04% | 1,978,748 | 4.10M |
| 54 | LGND | Ligand Pharmaceuticals Incorporated | 4.27B | -2.63% | 127,863 | 274.48M |
| 55 | CAI | Caris Life Sciences, Inc. | 4.11B | -4.59% | 4,696,980 | 907.29M |
| 56 | MANE | Veradermics, Incorporated | 4.11B | -5.99% | 476,743 | - |
| 57 | NAMS | NewAmsterdam Pharma Company N.V. | 4.07B | -3.90% | 1,132,471 | 22.57M |
| 58 | TVTX | Travere Therapeutics, Inc. | 3.96B | -3.42% | 1,650,974 | 536.20M |
| 59 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | -4.02% | 1,108,962 | 18.07M |
| 60 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.06% | 2,300,084 | 596.96M |
| 61 | ORKA | Oruka Therapeutics, Inc. | 3.74B | -3.08% | 1,392,935 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.66B | -3.12% | 1,292,619 | 1.10B |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.64B | -2.76% | 80,197 | 803.79M |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.56B | -2.71% | 989,084 | - |
| 65 | VKTX | Viking Therapeutics, Inc. | 3.51B | -4.54% | 1,769,294 | - |
| 66 | ERAS | Erasca, Inc. | 3.18B | -1.35% | 3,333,409 | - |
| 67 | RCUS | Arcus Biosciences, Inc. | 2.99B | -4.69% | 968,197 | 236.00M |
| 68 | TNGX | Tango Therapeutics, Inc. | 2.97B | -17.33% | 6,857,912 | 56.99M |
| 69 | DNLI | Denali Therapeutics Inc. | 2.96B | -3.97% | 2,154,144 | - |
| 70 | ALMS | Alumis Inc. | 2.91B | -7.15% | 943,725 | 8.40M |
| 71 | DYN | Dyne Therapeutics, Inc. | 2.86B | -5.42% | 1,197,182 | - |
| 72 | BEAM | Beam Therapeutics Inc. | 2.78B | -5.42% | 2,010,428 | 164.01M |
| 73 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.04% | 4,968,834 | 285.01M |
| 74 | GPCR | Structure Therapeutics Inc. | 2.75B | -2.89% | 467,297 | - |
| 75 | KLRA | Kailera Therapeutics, Inc. | 2.73B | -2.14% | 482,210 | - |
| 76 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | -4.14% | 720,843 | 535.08M |
| 77 | VERA | Vera Therapeutics, Inc. | 2.68B | -5.66% | 1,034,438 | - |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.67B | -1.16% | 1,600,505 | 415.62M |
| 79 | NBTX | Nanobiotix S.A. | 2.61B | -6.48% | 88,610 | 38.27M |
| 80 | IRON | Disc Medicine, Inc. | 2.55B | -4.07% | 825,262 | - |
| 81 | ELVN | Enliven Therapeutics, Inc. | 2.52B | -4.04% | 500,891 | - |
| 82 | IDYA | IDEAYA Biosciences, Inc. | 2.48B | -2.18% | 838,749 | 225.27M |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.46B | -3.42% | 682,146 | 865.00K |
| 84 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -3.10% | 1,519,285 | 670.00M |
| 85 | NKTR | Nektar Therapeutics | 2.38B | -4.99% | 1,272,965 | 55.63M |
| 86 | IMNM | Immunome, Inc. | 2.36B | -5.18% | 1,309,846 | 4.02M |
| 87 | RLAY | Relay Therapeutics, Inc. | 2.34B | -4.54% | 2,470,003 | 10.68M |
| 88 | ZLAB | Zai Lab Limited | 2.31B | 1.28% | 903,108 | 453.28M |
| 89 | KOD | Kodiak Sciences Inc. | 2.31B | -4.34% | 812,439 | - |
| 90 | DFTX | Definium Therapeutics, Inc. | 2.29B | -1.69% | 1,435,669 | - |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | 0.40% | 964,338 | - |
| 92 | TYRA | Tyra Biosciences, Inc. | 2.20B | 1.45% | 1,017,787 | - |
| 93 | GENB | Generate Biomedicines, Inc. | 2.04B | 3.43% | 1,442,599 | 30.30M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.02B | -5.84% | 896,407 | - |
| 95 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -3.58% | 2,373,731 | 52.04M |
| 96 | PHVS | Pharvaris N.V. | 1.99B | -0.88% | 444,226 | - |
| 97 | MESO | Mesoblast Limited | 1.98B | -0.60% | 162,026 | 65.38M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -3.54% | 1,112,195 | 298.30M |
| 99 | ADMA | ADMA Biologics, Inc. | 1.92B | -2.71% | 3,718,880 | 509.86M |
| 100 | NTLA | Intellia Therapeutics, Inc. | 1.91B | 4.43% | 14,834,310 | 66.09M |
| 101 | AAPG | Ascentage Pharma Group International | 1.88B | -3.37% | 29,112 | 82.08M |
| 102 | STOK | Stoke Therapeutics, Inc. | 1.87B | -4.08% | 673,552 | 32.08M |
| 103 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -6.05% | 4,571,081 | 2.18B |
| 104 | ANAB | AnaptysBio, Inc. | 1.84B | 1.54% | 448,347 | 232.39M |
| 105 | LKFT | Lakefront Biotherapeutics NV | 1.83B | -1.60% | 152,072 | 1.20B |
| 106 | SION | Sionna Therapeutics, Inc. | 1.82B | -5.73% | 273,179 | - |
| 107 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | -1.56% | 1,842,879 | 217.17M |
| 108 | OCS | Oculis Holding AG | 1.79B | 0.23% | 250,914 | 1.40M |
| 109 | RAPP | Rapport Therapeutics, Inc. | 1.77B | -2.32% | 230,863 | 20.00M |
| 110 | ZYME | Zymeworks Inc. | 1.75B | -0.13% | 639,623 | 81.26M |
| 111 | HRMY | Harmony Biosciences Holdings, Inc. | 1.74B | -2.18% | 471,075 | 899.11M |
| 112 | VRDN | Viridian Therapeutics, Inc. | 1.73B | -3.50% | 1,350,380 | 70.92M |
| 113 | TSHA | Taysha Gene Therapies, Inc. | 1.71B | -5.40% | 2,736,141 | 7.47M |
| 114 | QURE | uniQure N.V. | 1.71B | -2.52% | 1,450,179 | 18.09M |
| 115 | VCEL | Vericel Corporation | 1.69B | -0.33% | 448,985 | 292.09M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | -1.95% | 604,083 | 66.05M |
| 117 | CAPR | Capricor Therapeutics, Inc. | 1.67B | -3.42% | 869,057 | 11.13M |
| 118 | NRIX | Nurix Therapeutics, Inc. | 1.64B | -0.91% | 1,000,308 | 71.78M |
| 119 | PVLA | Palvella Therapeutics, Inc. | 1.64B | -3.98% | 258,448 | - |
| 120 | INVA | Innoviva, Inc. | 1.62B | -3.89% | 1,002,172 | 420.69M |
| 121 | INBX | Inhibrx Biosciences, Inc. | 1.59B | -6.47% | 394,236 | 1.30M |
| 122 | PGEN | Precigen, Inc. | 1.58B | -3.91% | 3,615,452 | 31.60M |
| 123 | RXRX | Recursion Pharmaceuticals, Inc. | 1.56B | -3.62% | 17,426,388 | 66.41M |
| 124 | MBX | MBX Biosciences, Inc. | 1.54B | -8.23% | 606,195 | - |
| 125 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | -1.99% | 7,853,227 | 285.61M |
| 126 | ARDX | Ardelyx, Inc. | 1.54B | -3.56% | 2,765,751 | 427.68M |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | -2.84% | 926,125 | 42.95M |
| 128 | NUVB | Nuvation Bio Inc. | 1.50B | -8.47% | 7,654,992 | 143.05M |
| 129 | NVAX | Novavax, Inc. | 1.49B | -3.10% | 4,079,973 | 596.34M |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.48B | 3.02% | 439,599 | - |
| 131 | VIR | Vir Biotechnology, Inc. | 1.48B | -3.30% | 1,437,974 | 65.50M |
| 132 | ATAI | AtaiBeckley Inc. | 1.47B | -0.62% | 2,885,830 | 3.49M |
| 133 | IMTX | Immatics N.V. | 1.46B | -2.69% | 358,336 | 43.00M |
| 134 | IMCR | Immunocore Holdings plc | 1.43B | -2.47% | 194,928 | 412.81M |
| 135 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.11% | 8,869,857 | 114.48M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.41B | -3.29% | 411,786 | 20.00M |
| 137 | URGN | UroGen Pharma Ltd. | 1.40B | -3.03% | 944,066 | 140.49M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.33B | -2.03% | 552,929 | - |
| 139 | GHRS | GH Research PLC | 1.33B | -3.69% | 201,139 | - |
| 140 | BHVN | Biohaven Ltd. | 1.32B | -2.88% | 2,023,028 | - |
| 141 | SLS | SELLAS Life Sciences Group, Inc. | 1.32B | -4.58% | 8,554,328 | - |
| 142 | WVE | Wave Life Sciences Ltd. | 1.30B | -1.88% | 4,227,026 | 71.80M |
| 143 | MPLT | MapLight Therapeutics, Inc. | 1.30B | -1.91% | 176,870 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.30B | -1.83% | 278,476 | - |
| 145 | FTRE | Fortrea Holdings Inc. | 1.29B | -4.07% | 1,100,932 | 2.71B |
| 146 | MLTX | MoonLake Immunotherapeutics | 1.28B | -4.57% | 585,569 | - |
| 147 | SVRA | Savara Inc. | 1.28B | -4.55% | 2,510,783 | - |
| 148 | ABCL | AbCellera Biologics Inc. | 1.25B | -7.05% | 8,869,314 | 79.21M |
| 149 | AVLN | Avalyn Pharma Inc. | 1.25B | -2.55% | 205,029 | - |
| 150 | COAG | Hemab Therapeutics Holdings, Inc. | 1.24B | -1.06% | 118,238 | - |
| 151 | SEPN | Septerna, Inc. | 1.21B | -4.84% | 573,801 | 72.26M |
| 152 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -1.66% | 1,223,931 | - |
| 153 | DBVT | DBV Technologies S.A. | 1.17B | -0.96% | 66,967 | 5.74M |
| 154 | ZBIO | Zenas BioPharma, Inc. | 1.16B | -2.96% | 642,859 | 10.00M |
| 155 | IVA | Inventiva S.A. | 1.16B | -1.98% | 284,579 | 7.94M |
| 156 | JBIO | Jade Biosciences, Inc. | 1.15B | -3.21% | 555,285 | - |
| 157 | AKTS | Aktis Oncology, Inc. | 1.08B | 0.26% | 142,825 | 8.28M |
| 158 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.07B | -3.26% | 1,538,467 | 204.73M |
| 159 | EYPT | EyePoint, Inc. | 1.04B | -6.72% | 447,472 | 7.61M |
| 160 | CRVS | Corvus Pharmaceuticals, Inc. | 1.04B | -9.88% | 3,488,742 | - |
| 161 | LXRX | Lexicon Pharmaceuticals, Inc. | 990.35M | -4.29% | 2,117,550 | 69.64M |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 966.74M | -2.60% | 766,858 | - |
| 163 | MNKD | MannKind Corporation | 954.66M | -4.04% | 4,962,203 | 360.78M |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 942.84M | -9.04% | 1,111,116 | 204.89M |
| 165 | PHAR | Pharming Group N.V. | 929.08M | -0.31% | 4,839 | 369.49M |
| 166 | DRTS | Alpha Tau Medical Ltd. | 911.78M | -0.48% | 901,304 | - |
| 167 | DSGN | Design Therapeutics, Inc. | 897.51M | -1.17% | 623,610 | - |
| 168 | SPTX | Seaport Therapeutics, Inc. | 893.25M | -0.56% | 611,624 | - |
| 169 | OMER | Omeros Corporation | 886.60M | -7.76% | 3,266,355 | 9.89M |
| 170 | MGTX | MeiraGTx Holdings plc | 870.53M | -5.53% | 768,588 | 79.76M |
| 171 | SANA | Sana Biotechnology, Inc. | 854.36M | -2.23% | 3,023,213 | - |
| 172 | ANNX | Annexon, Inc. | 853.62M | -2.98% | 1,850,600 | - |
| 173 | LBRX | LB Pharmaceuticals Inc | 850.55M | -5.57% | 255,966 | - |
| 174 | JANX | Janux Therapeutics, Inc. | 847.07M | -3.47% | 737,295 | 13.73M |
| 175 | ORIC | ORIC Pharmaceuticals, Inc. | 843.67M | -2.28% | 1,205,008 | - |
| 176 | ABUS | Arbutus Biopharma Corporation | 837.56M | -2.53% | 1,410,704 | 191.45M |
| 177 | TBPH | Theravance Biopharma, Inc. | 836.19M | -1.76% | 525,283 | 109.78M |
| 178 | XNCR | Xencor, Inc. | 831.87M | -5.56% | 895,133 | 97.36M |
| 179 | ODTX | Odyssey Therapeutics, Inc. | 831.21M | 1.73% | 405,143 | 2.98M |
| 180 | GERN | Geron Corporation | 827.56M | -7.86% | 16,158,372 | 196.12M |
| 181 | EVMN | Evommune, Inc. | 825.54M | 0.88% | 484,095 | 10.00M |
| 182 | KURA | Kura Oncology, Inc. | 818.50M | -5.34% | 1,516,359 | 71.64M |
| 183 | ANRO | Alto Neuroscience, Inc. | 805.51M | -2.59% | 376,330 | - |
| 184 | AURA | Aura Biosciences, Inc. | 800.21M | -3.01% | 491,714 | - |
| 185 | ABSI | Absci Corporation | 799.79M | -7.40% | 3,565,990 | 1.84M |
| 186 | VOR | Vor Biopharma Inc. | 792.74M | -2.92% | 649,459 | - |
| 187 | CTMX | CytomX Therapeutics, Inc. | 785.91M | -4.50% | 2,611,803 | 35.54M |
| 188 | SGP | SpyGlass Pharma, Inc. | 775.83M | -4.37% | 34,905 | - |
| 189 | DRUG | Bright Minds Biosciences Inc. | 763.26M | -0.22% | 269,881 | - |
| 190 | SPRY | ARS Pharmaceuticals, Inc. | 737.31M | -6.49% | 3,673,512 | 84.28M |
| 191 | RLMD | Relmada Therapeutics, Inc. | 723.73M | -7.01% | 1,440,636 | - |
| 192 | EIKN | Eikon Therapeutics, Inc. | 717.34M | 0.53% | 377,621 | - |
| 193 | TENX | Tenax Therapeutics, Inc. | 705.36M | 0.67% | 709,302 | - |
| 194 | ALLO | Allogene Therapeutics, Inc. | 690.31M | -6.54% | 6,969,196 | 22.00K |
| 195 | SLDB | Solid Biosciences Inc. | 681.27M | -9.31% | 2,022,240 | - |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 681.08M | - | 784,837 | - |
| 197 | CBIO | Crescent Biopharma, Inc. | 663.92M | -5.89% | 260,486 | 11.88M |
| 198 | ZVRA | Zevra Therapeutics, Inc. | 650.86M | -5.57% | 1,728,162 | 122.29M |
| 199 | STRO | Sutro Biopharma, Inc. | 645.65M | 1.43% | 261,164 | 102.48M |
| 200 | CADL | Candel Therapeutics, Inc. | 642.58M | -1.57% | 3,683,094 | - |
| 201 | ACRS | Aclaris Therapeutics, Inc. | 631.28M | -5.83% | 929,192 | 8.37M |
| 202 | GYRE | Gyre Therapeutics, Inc. | 598.49M | -6.43% | 94,305 | 117.05M |
| 203 | CRMD | CorMedix Inc. | 592.31M | -4.79% | 2,835,682 | 400.05M |
| 204 | TRAX | First Tracks Biotherapeutics, Inc. | 587.26M | -6.94% | 196,012 | - |
| 205 | FBRX | Forte Biosciences, Inc. | 586.10M | -3.55% | 177,665 | - |
| 206 | ARVN | Arvinas, Inc. | 585.85M | -3.61% | 968,096 | 89.40M |
| 207 | KYTX | Kyverna Therapeutics, Inc. | 574.43M | -11.64% | 1,195,416 | - |
| 208 | VALN | Valneva SE | 567.81M | -3.70% | 25,873 | 180.25M |
| 209 | ALT | Altimmune, Inc. | 554.25M | -2.40% | 2,286,710 | 36.00K |
| 210 | ANL | Adlai Nortye Ltd. | 540.40M | -2.53% | 90,732 | 5.00M |
| 211 | CABA | Cabaletta Bio, Inc. | 539.69M | -8.31% | 3,192,709 | - |
| 212 | RIGL | Rigel Pharmaceuticals, Inc. | 536.75M | -9.12% | 500,512 | 299.77M |
| 213 | MDXG | MiMedx Group, Inc. | 530.99M | 0.42% | 1,221,185 | 389.42M |
| 214 | PRME | Prime Medicine, Inc. | 529.21M | -6.39% | 3,114,618 | 4.03M |
| 215 | IMMX | Immix Biopharma, Inc. | 526.94M | -1.58% | 603,206 | - |
| 216 | TECX | Tectonic Therapeutic, Inc. | 526.26M | -6.41% | 298,092 | - |
| 217 | XOMA | XOMA Royalty Corporation | 523.02M | -0.70% | 102,505 | 48.56M |
| 218 | AGMB | AgomAb Therapeutics NV | 519.57M | -4.44% | 42,830 | - |
| 219 | CLYM | Climb Bio, Inc. | 515.90M | -4.68% | 655,215 | - |
| 220 | CTNM | Contineum Therapeutics, Inc. | 512.94M | -3.45% | 181,201 | - |
| 221 | PRTA | Prothena Corporation plc | 510.97M | -1.01% | 700,058 | 57.94M |
| 222 | DNA | Ginkgo Bioworks Holdings, Inc. | 503.65M | -1.78% | 1,045,724 | 151.40M |
| 223 | PROK | ProKidney Corp. | 501.26M | -2.92% | 884,533 | 893.00K |
| 224 | UPB | Upstream Bio, Inc. | 494.68M | 3.41% | 979,902 | 3.32M |
| 225 | FDMT | 4D Molecular Therapeutics, Inc. | 478.33M | -6.73% | 574,807 | 88.24M |
| 226 | AVTX | Avalo Therapeutics, Inc. | 473.91M | -6.68% | 1,534,181 | 59.00K |
| 227 | STTK | Shattuck Labs, Inc. | 473.14M | -6.15% | 265,321 | 1.00M |
| 228 | NGNE | Neurogene Inc. | 471.21M | -4.64% | 87,508 | 925.00K |
| 229 | OCGN | Ocugen, Inc. | 470.54M | -4.79% | 4,785,060 | 4.47M |
| 230 | ASMB | Assembly Biosciences, Inc. | 455.32M | -5.45% | 122,187 | 71.10M |
| 231 | OVID | Ovid Therapeutics Inc. | 455.09M | -6.07% | 1,252,595 | 7.12M |
| 232 | PRLD | Prelude Therapeutics Incorporated | 450.59M | 0.22% | 471,973 | 16.72M |
| 233 | ZURA | Zura Bio Limited | 447.84M | -2.28% | 525,746 | - |
| 234 | FULC | Fulcrum Therapeutics, Inc. | 445.78M | -5.91% | 361,365 | 80.00M |
| 235 | EPRX | Eupraxia Pharmaceuticals Inc. | 444.71M | -3.35% | 185,422 | - |
| 236 | VTVT | vTv Therapeutics Inc. | 442.96M | -7.12% | 45,329 | 36.84M |
| 237 | PRTC | PureTech Health plc | 442.35M | -3.17% | 5,464 | 4.66M |
| 238 | AUTL | Autolus Therapeutics plc | 433.81M | 2.52% | 1,482,171 | 75.39M |
| 239 | REPL | Replimune Group, Inc. | 431.03M | 5.88% | 5,875,124 | - |
| 240 | SGMT | Sagimet Biosciences Inc. | 426.09M | -6.38% | 744,645 | - |
| 241 | IPSC | Century Therapeutics, Inc. | 422.03M | -1.68% | 751,237 | 109.16M |
| 242 | LYEL | Lyell Immunopharma, Inc. | 418.12M | -5.78% | 107,622 | 31.00K |
| 243 | ADCT | ADC Therapeutics SA | 413.37M | -3.27% | 1,103,265 | 79.18M |
| 244 | LXEO | Lexeo Therapeutics, Inc. | 399.68M | -7.45% | 787,385 | - |
| 245 | MNPR | Monopar Therapeutics Inc. | 397.04M | -2.82% | 135,507 | - |
| 246 | BNTC | Benitec Biopharma Inc. | 394.73M | -3.04% | 103,035 | - |
| 247 | CCCC | C4 Therapeutics, Inc. | 392.24M | -1.93% | 2,282,336 | 34.86M |
| 248 | ENTA | Enanta Pharmaceuticals, Inc. | 389.15M | -2.90% | 221,933 | 69.21M |
| 249 | VSTM | Verastem, Inc. | 379.61M | -8.28% | 2,210,299 | 49.59M |
| 250 | VNDA | Vanda Pharmaceuticals Inc. | 377.65M | -1.72% | 1,106,098 | 217.78M |
| 251 | GLSI | Greenwich LifeSciences, Inc. | 376.98M | 4.77% | 219,589 | - |
| 252 | LRMR | Larimar Therapeutics, Inc. | 373.69M | -7.97% | 3,491,764 | - |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 371.62M | -1.50% | 263,887 | 9.01M |
| 254 | YDES | YD Bio Limited | 363.91M | 2.27% | 2,129 | 510.36K |
| 255 | IFRX | InflaRx N.V. | 363.81M | 3.78% | 1,450,840 | 33.82K |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 354.88M | -4.41% | 1,928,759 | - |
| 257 | PBYI | Puma Biotechnology, Inc. | 352.22M | -3.76% | 188,793 | 227.18M |
| 258 | RZLT | Rezolute, Inc. | 348.92M | -1.76% | 891,460 | - |
| 259 | IRD | Opus Genetics, Inc. | 342.73M | -3.42% | 917,915 | 11.98M |
| 260 | IVVD | Invivyd, Inc. | 342.19M | 4.31% | 7,324,867 | 53.43M |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 338.45M | 5.52% | 602,528 | 51.00M |
| 262 | NMRA | Neumora Therapeutics, Inc. | 336.15M | -6.60% | 829,021 | - |
| 263 | CMPX | Compass Therapeutics, Inc. | 334.96M | -6.06% | 3,874,410 | 850.00K |
| 264 | IMRX | Immuneering Corporation | 333.84M | 0.39% | 570,920 | - |
| 265 | AVIR | Atea Pharmaceuticals, Inc. | 328.11M | -3.98% | 459,906 | - |
| 266 | DMAC | DiaMedica Therapeutics Inc. | 327.07M | -4.56% | 123,192 | - |
| 267 | SRZN | Surrozen, Inc. | 323.35M | -5.76% | 71,740 | 7.49M |
| 268 | NAUT | Nautilus Biotechnology, Inc. | 318.97M | -4.20% | 333,116 | - |
| 269 | OABI | OmniAb, Inc. | 316.04M | -0.46% | 915,650 | 28.94M |
| 270 | ABEO | Abeona Therapeutics Inc. | 312.90M | -1.96% | 1,516,137 | 14.54M |
| 271 | LCTX | Lineage Cell Therapeutics, Inc. | 311.62M | -4.58% | 1,017,454 | 14.78M |
| 272 | BCYC | Bicycle Therapeutics plc | 310.20M | -4.71% | 377,131 | 63.50M |
| 273 | PALI | Palisade Bio, Inc. | 306.39M | 1.10% | 1,811,925 | - |
| 274 | CLLS | Cellectis S.A. | 302.50M | -2.46% | 37,524 | 75.11M |
| 275 | RGNX | REGENXBIO Inc. | 295.71M | -8.48% | 4,346,478 | 87.82M |
| 276 | ARMP | Armata Pharmaceuticals, Inc. | 295.40M | -1.83% | 77,153 | 5.20M |
| 277 | IKT | Inhibikase Therapeutics, Inc. | 294.83M | -6.99% | 947,904 | 1.00 |
| 278 | ELDN | Eledon Pharmaceuticals, Inc. | 293.75M | -3.80% | 992,466 | - |
| 279 | NVCT | Nuvectis Pharma, Inc. | 292.84M | -11.33% | 187,484 | - |
| 280 | NAGE | Niagen Bioscience, Inc. | 291.31M | -3.95% | 1,403,710 | 130.42M |
| 281 | NGEN | NervGen Pharma Corp. | 288.52M | -3.91% | 409,924 | - |
| 282 | ZNTL | Zentalis Pharmaceuticals, Inc. | 288.30M | -0.98% | 918,058 | 26.87M |
| 283 | SLN | Silence Therapeutics plc | 288.13M | -14.45% | 188,514 | 839.00K |
| 284 | TARA | Protara Therapeutics, Inc. | 286.64M | -3.77% | 1,122,891 | - |
| 285 | ACHV | Achieve Life Sciences, Inc. | 281.64M | -8.64% | 1,210,740 | - |
| 286 | ACIU | AC Immune SA | 276.77M | -0.36% | 357,191 | 4.62M |
| 287 | ALXO | ALX Oncology Holdings Inc. | 273.16M | -0.49% | 468,128 | - |
| 288 | MGNX | MacroGenics, Inc. | 270.13M | 2.16% | 1,901,468 | 157.08M |
| 289 | AVXL | Anavex Life Sciences Corp. | 269.67M | -5.52% | 997,534 | - |
| 290 | CGEN | Compugen Ltd. | 260.02M | -9.24% | 834,218 | 72.76M |
| 291 | SABS | SAB Biotherapeutics, Inc. | 260.02M | -4.88% | 944,588 | 114.70K |
| 292 | EDIT | Editas Medicine, Inc. | 256.51M | -8.07% | 1,277,170 | 38.69M |
| 293 | TNXP | Tonix Pharmaceuticals Holding Corp. | 250.91M | 11.71% | 724,662 | 17.56M |
| 294 | CHRS | Coherus Oncology, Inc. | 242.17M | -3.68% | 1,381,956 | 46.88M |
| 295 | ARTV | Artiva Biotherapeutics, Inc. | 241.73M | -8.43% | 524,524 | 251.00K |
| 296 | ALEC | Alector, Inc. | 239.81M | -6.09% | 1,104,558 | 18.42M |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 237.72M | 5.88% | 16,217 | 19.39M |
| 298 | HELP | Cybin Inc. | 233.67M | -7.71% | 992,626 | - |
| 299 | WHWK | Whitehawk Therapeutics, Inc. | 232.31M | -7.84% | 245,224 | 7.15M |
| 300 | ADAG | Adagene Inc. | 231.25M | -4.37% | 23,474 | 7.67M |
| 301 | LENZ | LENZ Therapeutics, Inc. | 230.14M | 0.69% | 994,295 | 20.99M |
| 302 | TRDA | Entrada Therapeutics, Inc. | 229.89M | -6.59% | 327,046 | 5.74M |
| 303 | NERV | Minerva Neurosciences, Inc. | 228.42M | -5.27% | 90,311 | - |
| 304 | VYGR | Voyager Therapeutics, Inc. | 227.49M | -11.20% | 837,207 | 36.49M |
| 305 | CAMP | Camp4 Therapeutics Corporation | 223.80M | -1.60% | 34,763 | 3.93M |
| 306 | CDXS | Codexis, Inc. | 223.61M | -4.28% | 660,195 | 78.09M |
| 307 | OBIO | Orchestra BioMed Holdings, Inc. | 222.76M | -9.49% | 439,337 | 32.72M |
| 308 | FHTX | Foghorn Therapeutics Inc. | 222.53M | -6.19% | 257,874 | 28.22M |
| 309 | UNCY | Unicycive Therapeutics, Inc. | 220.54M | -3.50% | 809,863 | - |
| 310 | RNAC | Cartesian Therapeutics, Inc. | 216.84M | -10.76% | 120,333 | 1.78M |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 212.32M | -4.60% | 548,260 | 54.71M |
| 312 | MDWD | MediWound Ltd. | 210.91M | -2.29% | 50,433 | 16.96M |
| 313 | NBP | NovaBridge Biosciences | 210.48M | -5.21% | 865,038 | - |
| 314 | CRBU | Caribou Biosciences, Inc. | 210.27M | - | 1,923,805 | 11.20M |
| 315 | KROS | Keros Therapeutics, Inc. | 207.77M | -4.46% | 572,195 | 33.18M |
| 316 | HUMA | Humacyte, Inc. | 206.50M | -6.99% | 7,490,254 | 2.02M |
| 317 | RNA | Atrium Therapeutics, Inc. | 205.26M | -0.30% | 234,322 | 18.62M |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 205.10M | -3.47% | 403,358 | - |
| 319 | MIST | Milestone Pharmaceuticals Inc. | 204.76M | -7.67% | 2,020,688 | 1.78M |
| 320 | FATE | Fate Therapeutics, Inc. | 204.56M | -7.63% | 2,067,665 | 6.32M |
| 321 | CNTX | Context Therapeutics Inc. | 198.46M | -7.30% | 570,971 | - |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 195.63M | -7.93% | 167,562 | - |
| 323 | ELTX | Elicio Therapeutics, Inc. | 195.55M | -2.48% | 118,952 | - |
| 324 | NKTX | Nkarta, Inc. | 188.88M | -6.05% | 730,247 | - |
| 325 | ORMP | Oramed Pharmaceuticals Inc. | 187.67M | -1.90% | 175,416 | 2.00M |
| 326 | DTIL | Precision BioSciences, Inc. | 187.59M | -10.36% | 239,665 | 45.07M |
| 327 | TNYA | Tenaya Therapeutics, Inc. | 186.03M | -8.31% | 7,152,744 | 225.00K |
| 328 | IPHA | Innate Pharma S.A. | 181.81M | -6.91% | 209,704 | 10.57M |
| 329 | TLSA | Tiziana Life Sciences Ltd | 174.84M | -5.52% | 97,366 | - |
| 330 | ENLV | Enlivex Ltd. | 173.70M | -1.58% | 224,885 | - |
| 331 | KPTI | Karyopharm Therapeutics Inc. | 172.91M | -13.82% | 997,924 | 146.07M |
| 332 | ANTX | AN2 Therapeutics, Inc. | 170.98M | 2.37% | 408,710 | - |
| 333 | PRQR | ProQR Therapeutics N.V. | 167.52M | -3.64% | 413,819 | 15.73M |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 164.68M | -4.60% | 390,233 | - |
| 335 | IMUX | Immunic, Inc. | 164.55M | -4.58% | 161,698 | - |
| 336 | SPRO | Spero Therapeutics, Inc. | 161.55M | 1.09% | 938,902 | 61.19M |
| 337 | HRTX | Heron Therapeutics, Inc. | 160.89M | -6.84% | 1,872,776 | 150.71M |
| 338 | PLX | Protalix BioTherapeutics, Inc. | 159.53M | -1.00% | 1,066,094 | 76.38M |
| 339 | BDTX | Black Diamond Therapeutics, Inc. | 157.58M | -3.85% | 626,386 | 70.00M |
| 340 | MENS | Jyong Biotech Ltd. | 154.47M | -3.43% | 55,197 | - |
| 341 | KZIA | Kazia Therapeutics Limited | 150.38M | -4.84% | 164,825 | 1.27M |
| 342 | AGEN | Agenus Inc. | 148.71M | - | 511,890 | 123.87M |
| 343 | ALPS | Alps Group Inc | 147.26M | 2.91% | 124,985 | 3.74M |
| 344 | HURA | TuHURA Biosciences, Inc. | 146.87M | -7.97% | 614,397 | - |
| 345 | KRRO | Korro Bio, Inc. | 146.82M | -8.12% | 110,058 | 3.84M |
| 346 | SPRB | Spruce Biosciences, Inc. | 145.33M | -8.85% | 48,926 | 697.00K |
| 347 | MOLN | Molecular Partners AG | 143.91M | - | 4,617 | 856.30K |
| 348 | PYXS | Pyxis Oncology, Inc. | 143.31M | 3.17% | 986,688 | 13.86M |
| 349 | GALT | Galectin Therapeutics Inc. | 142.85M | -7.66% | 366,269 | - |
| 350 | NTHI | NeOnc Technologies Holdings, Inc. | 138.54M | 0.73% | 52,042 | 39.99K |
| 351 | EQ | Equillium, Inc. | 137.83M | -15.83% | 509,014 | 4.39M |
| 352 | GUTS | Fractyl Health, Inc. | 136.53M | -9.79% | 2,791,390 | 3.00K |
| 353 | CNTB | Connect Biopharma Holdings Limited | 134.52M | -4.03% | 114,301 | 233.00K |
| 354 | ACOG | Alpha Cognition Inc. | 131.08M | 5.99% | 96,129 | 10.22M |
| 355 | GNLX | Genelux Corporation | 129.67M | -3.95% | 152,229 | 8.00K |
| 356 | OKUR | OnKure Therapeutics, Inc. | 127.65M | -5.39% | 130,968 | - |
| 357 | PLYX | Polaryx Therapeutics, Inc. | 126.41M | -21.70% | 315,258 | - |
| 358 | TTRX | Turn Therapeutics Inc. | 120.64M | 0.75% | 28,928 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 116.35M | -5.70% | 152,043 | 7.94M |
| 360 | EDSA | Edesa Biotech, Inc. | 115.96M | -10.68% | 168,869 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 115.22M | -4.97% | 2,750,157 | - |
| 362 | CRDF | Cardiff Oncology, Inc. | 114.18M | -3.47% | 883,083 | 593.00K |
| 363 | KLRS | Kalaris Therapeutics, Inc. | 113.47M | -5.46% | 33,842 | - |
| 364 | NRXP | NRx Pharmaceuticals, Inc. | 108.35M | 2.18% | 2,251,986 | 1.23M |
| 365 | RANI | Rani Therapeutics Holdings, Inc. | 107.80M | -2.70% | 994,049 | 1.63M |
| 366 | VRCA | Verrica Pharmaceuticals Inc. | 107.71M | -9.78% | 81,594 | 37.16M |
| 367 | PEPG | PepGen Inc. | 107.21M | -6.06% | 716,568 | - |
| 368 | QTTB | Q32 Bio Inc. | 106.83M | 0.80% | 113,342 | 53.74M |
| 369 | INO | Inovio Pharmaceuticals, Inc. | 106.52M | -4.41% | 1,920,939 | 65.34K |
| 370 | LONA | LeonaBio, Inc. | 105.77M | 2.36% | 33,986 | - |
| 371 | CGTX | Cognition Therapeutics, Inc. | 101.86M | -5.00% | 765,645 | - |
| 372 | ALDX | Aldeyra Therapeutics, Inc. | 101.34M | 1.20% | 1,175,948 | - |
| 373 | VANI | Vivani Medical, Inc. | 100.90M | -2.50% | 183,135 | - |
| 374 | CBUS | Cibus, Inc. | 99.93M | -7.09% | 342,063 | 3.64M |
| 375 | AARD | Aardvark Therapeutics, Inc. | 99.70M | -32.10% | 745,025 | - |
| 376 | ONCY | Oncolytics Biotech Inc. | 98.71M | -2.62% | 861,100 | - |
| 377 | BMEA | Biomea Fusion, Inc. | 97.60M | -5.59% | 1,913,877 | - |
| 378 | SEER | Seer, Inc. | 97.04M | -1.71% | 230,184 | 15.17M |
| 379 | ANIX | Anixa Biosciences, Inc. | 94.55M | -2.42% | 110,330 | - |
| 380 | PMN | ProMIS Neurosciences, Inc. | 93.17M | -1.80% | 3,416 | - |
| 381 | NRXS | NeurAxis, Inc. | 90.55M | -5.75% | 110,507 | 4.28M |
| 382 | PTHS | Pelthos Therapeutics Inc. | 89.66M | -3.50% | 8,039 | 16.80M |
| 383 | CSBR | Champions Oncology, Inc. | 86.10M | -0.16% | 2,755 | 57.95M |
| 384 | PYPD | PolyPid Ltd. | 85.11M | 1.83% | 110,033 | - |
| 385 | ATHE | Alterity Therapeutics Limited | 82.93M | -13.70% | 76,879 | 4.43M |
| 386 | EXOZ | eXoZymes, Inc. | 82.75M | -2.59% | 138 | -700.00 |
| 387 | OKYO | OKYO Pharma Limited | 82.39M | -2.48% | 71,051 | - |
| 388 | RNTX | Rein Therapeutics Inc. | 81.94M | -7.08% | 683,823 | - |
| 389 | ATRA | Atara Biotherapeutics, Inc. | 81.55M | -0.10% | 226,108 | 23.14M |
| 390 | ICCC | ImmuCell Corporation | 80.70M | 7.99% | 60,599 | 27.64M |
| 391 | ACET | Adicet Bio, Inc. | 80.65M | -8.68% | 138,825 | - |
| 392 | FBIO | Fortress Biotech, Inc. | 80.06M | 4.78% | 771,528 | 63.26M |
| 393 | GOSS | Gossamer Bio, Inc. | 79.80M | 3.03% | 5,500,852 | 48.47M |
| 394 | OSTX | OS Therapies Incorporated | 79.03M | - | 861,706 | - |
| 395 | MAIA | MAIA Biotechnology, Inc. | 76.45M | -7.35% | 534,418 | - |
| 396 | ACRV | Acrivon Therapeutics, Inc. | 75.76M | -7.81% | 696,680 | - |
| 397 | RLYB | Rallybio Corporation | 75.64M | 0.63% | 53,607 | 858.00K |
| 398 | XBIT | XBiotech Inc. | 75.00M | -1.60% | 32,445 | - |
| 399 | CUE | Cue Biopharma, Inc. | 74.91M | -9.16% | 180,187 | 27.47M |
| 400 | PDSB | PDS Biotechnology Corporation | 74.79M | -6.29% | 956,319 | - |
| 401 | GANX | Gain Therapeutics, Inc. | 74.64M | -3.85% | 564,048 | - |
| 402 | MCRB | Seres Therapeutics, Inc. | 73.59M | -4.86% | 16,940 | 1.15M |
| 403 | ANVS | Annovis Bio, Inc. | 71.37M | -3.29% | 854,584 | - |
| 404 | PLRX | Pliant Therapeutics, Inc. | 71.20M | -1.29% | 439,110 | - |
| 405 | PMVP | PMV Pharmaceuticals, Inc. | 68.79M | -3.01% | 499,043 | - |
| 406 | MNOV | MediciNova, Inc. | 68.42M | -0.71% | 17,835 | 409.66K |
| 407 | IMA | ImageneBio, Inc. | 64.07M | -3.89% | 16,256 | 800.00K |
| 408 | ACTU | Actuate Therapeutics, Inc. | 62.12M | -9.66% | 85,616 | - |
| 409 | ENTX | Entera Bio Ltd. | 62.02M | -4.55% | 84,713 | 42.00K |
| 410 | DWTX | Dogwood Therapeutics, Inc. | 61.12M | -7.58% | 114,855 | - |
| 411 | TCRX | TScan Therapeutics, Inc. | 60.10M | -9.91% | 840,839 | 9.14M |
| 412 | LIXT | Lixte Biotechnology Holdings, Inc. | 59.95M | 2.38% | 149,629 | - |
| 413 | IMMP | Immutep Limited | 59.94M | 15.13% | 2,406,236 | 5.28M |
| 414 | HYFT | MindWalk Holdings Corp. | 59.10M | -5.56% | 100,605 | 20.70M |
| 415 | IBO | Impact BioMedical Inc. | 57.96M | -2.25% | 41,212 | 39.00K |
| 416 | FLNA | Filana Therapeutics, Inc. | 57.00M | -4.84% | 250,939 | - |
| 417 | CING | Cingulate Inc. | 55.99M | 4.10% | 461,381 | - |
| 418 | BYSI | BeyondSpring Inc. | 55.92M | -7.48% | 14,968 | 1.88M |
| 419 | TIL | Instil Bio, Inc. | 54.93M | 0.68% | 37,049 | - |
| 420 | KALA | KALA BIO, Inc. | 54.47M | -5.18% | 51,506 | - |
| 421 | INKT | MiNK Therapeutics, Inc. | 53.41M | 2.00% | 36,569 | - |
| 422 | IBIO | iBio, Inc. | 53.13M | -5.77% | 425,632 | 300.00K |
| 423 | XLO | Xilio Therapeutics, Inc. | 50.02M | -5.11% | 36,897 | 53.48M |
| 424 | ATYR | aTyr Pharma, Inc. | 49.42M | -9.98% | 3,538,060 | 190.00K |
| 425 | MGX | Metagenomi Therapeutics, Inc. | 49.32M | -2.96% | 142,877 | 22.33M |
| 426 | RADX | Radiopharm Theranostics Limited | 48.91M | -0.42% | 73,169 | 10.86M |
| 427 | HYPD | Hyperion DeFi, Inc. | 47.73M | -7.18% | 429,915 | 813.46K |
| 428 | ESLA | Estrella Immunopharma, Inc. | 47.36M | -7.88% | 27,997 | - |
| 429 | NTRB | Nutriband Inc. | 43.52M | -0.28% | 5,414 | 2.04M |
| 430 | TELO | Telomir Pharmaceuticals, Inc. | 43.32M | -0.79% | 79,345 | - |
| 431 | LITS | Lite Strategy, Inc. | 42.54M | -4.10% | 637,908 | - |
| 432 | ATOS | Atossa Therapeutics, Inc. | 41.77M | -5.83% | 46,173 | - |
| 433 | INMB | INmune Bio Inc. | 41.21M | -7.74% | 870,254 | 50.00K |
| 434 | QNTM | Quantum BioPharma Ltd. | 40.32M | -0.87% | 379,992 | - |
| 435 | ATNM | Actinium Pharmaceuticals, Inc. | 38.97M | -2.34% | 36,440 | 90.00K |
| 436 | MREO | Mereo BioPharma Group plc | 38.55M | -1.83% | 1,146,468 | 500.00K |
| 437 | TVRD | Tvardi Therapeutics, Inc. | 37.53M | 1.01% | 30,016 | - |
| 438 | RNXT | RenovoRx, Inc. | 36.94M | -4.09% | 647,593 | 1.12M |
| 439 | PSTV | Plus Therapeutics, Inc. | 36.03M | -8.85% | 171,820 | 5.21M |
| 440 | ALGS | Aligos Therapeutics, Inc. | 35.33M | -14.65% | 179,284 | 4.71M |
| 441 | LTRN | Lantern Pharma Inc. | 35.20M | 0.32% | 528,361 | - |
| 442 | NXTC | NextCure, Inc. | 35.14M | -4.98% | 48,736 | - |
| 443 | PLUR | Pluri Inc. | 33.87M | -0.88% | 7,992 | 1.34M |
| 444 | VERU | Veru Inc. | 33.87M | 0.96% | 57,781 | 16.89M |
| 445 | BOLD | Boundless Bio, Inc. | 33.58M | -3.35% | 157,854 | - |
| 446 | GRCE | Grace Therapeutics, Inc. | 33.42M | -1.37% | 268,402 | - |
| 447 | TVGN | Tevogen Bio Holdings Inc. | 33.11M | -15.61% | 20,834 | - |
| 448 | APLM | Apollomics, Inc. | 32.94M | 10.29% | 12,477 | 8.84M |
| 449 | EVAX | Evaxion A/S | 32.69M | -4.85% | 26,209 | 7.53M |
| 450 | PTN | Palatin Technologies, Inc. | 32.25M | -3.45% | 22,855 | 12.88M |
| 451 | NNVC | NanoViricides, Inc. | 31.96M | -14.94% | 622,548 | - |
| 452 | CRVO | CervoMed Inc. | 31.85M | -8.51% | 117,815 | 4.01M |
| 453 | DARE | Daré Bioscience, Inc. | 31.59M | -24.13% | 1,222,582 | 1.03M |
| 454 | SNTI | Senti Biosciences Holdings, Inc. | 31.46M | -2.88% | 171,925 | 22.00K |
| 455 | BCTX | BriaCell Therapeutics Corp. | 30.28M | -25.43% | 1,666,709 | - |
| 456 | NRSN | NeuroSense Therapeutics Ltd. | 29.22M | -2.86% | 41,049 | - |
| 457 | LSTA | Lisata Therapeutics, Inc. | 28.63M | 2.92% | 23,225 | 170.00K |
| 458 | SKYE | Skye Bioscience, Inc. | 28.58M | -6.61% | 192,890 | - |
| 459 | IGC | IGC Pharma, Inc. | 28.26M | -4.35% | 231,556 | 1.11M |
| 460 | BRNS | Barinthus Biotherapeutics plc | 27.76M | -4.42% | 10,748 | 14.97M |
| 461 | PLRZ | Polyrizon Ltd. | 27.70M | -1.46% | 27,516 | - |
| 462 | KYNB | Kyntra Bio, Inc. | 27.61M | -2.71% | 9,950 | 7.44M |
| 463 | SNSE | Sensei Biotherapeutics, Inc. | 27.38M | 3.08% | 40,968 | - |
| 464 | ABVC | ABVC BioPharma, Inc. | 26.93M | 0.93% | 68,610 | 797.92K |
| 465 | DYAI | Dyadic International, Inc. | 26.31M | 4.64% | 44,418 | 3.09M |
| 466 | TPST | Tempest Therapeutics, Inc. | 26.25M | -12.44% | 266,712 | - |
| 467 | NEUP | Neuphoria Therapeutics Inc. | 25.50M | -7.07% | 79,662 | 14.99M |
| 468 | HOWL | Werewolf Therapeutics, Inc. | 25.03M | -5.07% | 443,829 | 1.14M |
| 469 | VTGN | Vistagen Therapeutics, Inc. | 24.76M | -3.95% | 643,593 | 789.00K |
| 470 | SER | Serina Therapeutics, Inc. | 24.43M | -4.65% | 153,137 | 130.00K |
| 471 | GRDX | GridAI Technologies Corp. | 23.99M | 6.32% | 618,820 | - |
| 472 | OTLK | Outlook Therapeutics, Inc. | 23.86M | -2.19% | 2,654,037 | 205.70K |
| 473 | JSPR | Jasper Therapeutics, Inc. | 23.80M | -11.36% | 661,756 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 23.68M | -2.74% | 14,091 | 3.55M |
| 475 | CELU | Celularity Inc. | 23.31M | -0.38% | 104,618 | 26.55M |
| 476 | VYNE | VYNE Therapeutics Inc. | 22.33M | -0.06% | 106,392 | 570.00K |
| 477 | ALLR | Allarity Therapeutics, Inc. | 20.87M | -10.60% | 223,875 | 320.00K |
| 478 | LGVN | Longeveron Inc. | 19.63M | -4.57% | 877,960 | 1.22M |
| 479 | CRIS | Curis, Inc. | 19.60M | -4.50% | 248,060 | 7.06M |
| 480 | KTTA | Pasithea Therapeutics Corp. | 19.46M | -1.78% | 549,444 | - |
| 481 | TRAW | Traws Pharma, Inc. | 19.10M | 15.34% | 1,937,558 | 2.79M |
| 482 | CTXR | Citius Pharmaceuticals, Inc. | 18.99M | -2.72% | 697,987 | 3.94M |
| 483 | AEON | AEON Biopharma, Inc. | 18.98M | -9.91% | 95,939 | - |
| 484 | OSRH | OSR Holdings, Inc. | 18.88M | -5.02% | 1,183,876 | 2.63M |
| 485 | QNCX | Quince Therapeutics, Inc. | 18.75M | -2.54% | 595,629 | - |
| 486 | LPCN | Lipocine Inc. | 18.14M | -3.00% | 55,638 | 2.00M |
| 487 | XCUR | Exicure, Inc. | 18.10M | -10.69% | 33,051 | 500.00K |
| 488 | NCEL | NewcelX Ltd. | 17.28M | -6.41% | 13,286 | - |
| 489 | PASG | Passage Bio, Inc. | 16.74M | -2.61% | 42,442 | - |
| 490 | COCP | Cocrystal Pharma, Inc. | 16.54M | -4.76% | 101,244 | - |
| 491 | ERNA | Ernexa Therapeutics Inc. | 15.89M | 42.57% | 1,374,290 | 1,000.00 |
| 492 | ICU | SeaStar Medical Holding Corporation | 15.79M | -5.95% | 65,074 | 1.44M |
| 493 | CVKD | Cadrenal Therapeutics, Inc. | 15.56M | -4.08% | 47,562 | - |
| 494 | GNTA | Genenta Science S.p.A. | 14.82M | -0.32% | 28,717 | - |
| 495 | LEXX | Lexaria Bioscience Corp. | 14.68M | -3.06% | 43,792 | 368.00K |
| 496 | INAB | IN8bio, Inc. | 14.67M | -6.29% | 130,755 | - |
| 497 | GDTC | CytoMed Therapeutics Limited | 13.73M | 31.79% | 89,075 | 669.28K |
| 498 | BLRX | BioLineRx Ltd. | 13.46M | -2.61% | 5,383 | 1.18M |
| 499 | TOVX | Theriva Biologics, Inc. | 13.35M | -9.35% | 2,553,430 | 300.00K |
| 500 | HIND | Vyome Holdings, Inc. | 13.27M | -1.56% | 21,885 | 152.72K |